TBT Pharma
Baltimore, US · Founded 2019 · Delaware corporation · 1 known investors
Founders & leadership
SG
Steve GirgentiNamed on SEC filing
Board
NC
IT
Investors · 1
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2020
▶$700KraisedJan 2021 · 4 investors · BiotechnologyRule 506(b)
▶$700KraisedJan 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neil CohenDirector
- Ian TolfreeExecutive Officer, Director, Promoter
- Steve GirgentiDirector
- Offering amount
- $2M
- Amount sold
- $700K
- Minimum investment
- $25K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are TBT Pharma's investors?
- TBT Pharma's investors include Emerald Development Managers.
- How much funding has TBT Pharma raised?
- TBT Pharma has disclosed $700K raised across 1 round.
- Where is TBT Pharma headquartered?
- TBT Pharma is headquartered in Baltimore, US.